Table 2.
Univariate Analysis of Predictors of Bleeding between 6 and 12 Months
| Predictors | Any Bleeding between 6 and 12 Months | P-Values | |
|---|---|---|---|
| Yes (n = 71) | No (n = 1,969) | ||
| Female gender | 27 (38.0) | 517 (26.3) | 0.039 |
| Age, years | 63.6 ± 11.7 | 60.6 ± 11.1 | 0.027 |
| Smoking history | 36 (50.7) | 986 (50.1) | 1.000 |
| Diabetes mellitus | 23 (32.4) | 404 (20.5) | 0.025 |
| Hypertension | 39 (54.9) | 1,099 (55.8) | 0.904 |
| Hyperlipidemia | 20 (28.2) | 596 (30.3) | 0.793 |
| Family history of CHD | 11 (16.2) | 151 (8.4) | 0.043 |
| Prior stroke | 19 (26.8) | 328 (16.7) | 0.035 |
| Prior MI | 6 (8.6) | 239 (12.3) | 0.456 |
| Heart failure | 6 (8.5) | 183 (9.3) | 1.000 |
| PCI indications | 0.889 | ||
| Silent ischemia | 4 (5.7) | 77 (3.8) | |
| Stable angina | 4 (5.7) | 127 (6.3) | |
| Unstable angina | 37 (52.9) | 1,068 (53.2) | |
| Recent MI (24 hours to 30 days) | 14 (20.0) | 360 (17.9) | |
| Acute MI within 24 hours | 11 (15.7) | 375 (18.7) | |
| Multivessel stenting | 24 (33.8) | 532 (27.0) | 0.222 |
| Stent no. per patient | 2.00 ± 1.23 | 1.79 ± 1.12 | 0.128 |
| Number of target vessels | 1.59 ± 0.79 | 1.48 ± 0.76 | 0.208 |
| Mean RVD, mm | 3.01 ± 0.47 | 2.99 ± 0.50 | 0.751 |
| Mean lesion length, mm | 26.42 ± 15.25 | 26.96 ± 12.96 | 0.734 |
| Duration of DAPT, days | 217.4 ± 67.0 | 200.0 ± 50.7 | 0.005 |
| Medications | |||
| Anticoagulant agents | 6 (8.5) | 157 (8.0) | 0.884 |
| Proton pump inhibitors | 58 (81.7) | 1,592 (80.9) | 0.860 |
CHD, coronary heart disease; MI, myocardial infarction; PCI, percutaneous coronary intervention; RVD, reference vessel diameter; DAPT, dual antiplatelet therapy.